{"id":15319,"date":"2026-06-03T17:00:00","date_gmt":"2026-06-03T15:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=b5838cb777b29bca4c9af237baf2c52c"},"modified":"2026-06-03T17:00:00","modified_gmt":"2026-06-03T15:00:00","slug":"nirrin-technologies-launches-talos-a-protein-quantitation-system-designed-for-modern-biopharmaceutical-manufacturing-workflows","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=15319","title":{"rendered":"Nirrin Technologies Launches TALOS\u2122, a Protein Quantitation System Designed for Modern Biopharmaceutical Manufacturing Workflows"},"content":{"rendered":"<ul class=\"bwlistdisc\">\n<li>\nDelivers rapid protein quantitation across bioprocess workflows from harvest to final formulation<\/li>\n<li>\nReduces operator-dependent variables, simplifying protein quantitation for consistent and reliable operation across users and sites<\/li>\n<li>\nSupports protein quantitation from process development through GMP manufacturing with at-line, in-line, and in situ deployment modes<\/li>\n<\/ul><p>BILLERICA, Mass.--(BUSINESS WIRE)--<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nirrin.tech%2F&amp;esheet=54546048&amp;newsitemid=20260603645287&amp;lan=en-US&amp;anchor=Nirrin+Technologies&amp;index=1&amp;md5=bd2e388e5d8941cc7f6d3228d01ccea8\" rel=\"nofollow\" shape=\"rect\">Nirrin Technologies<\/a>, a developer of analytical tools designed to transform bioprocess workflows, today announced the commercial launch of TALOS\u2122, a direct protein quantitation system built on the company\u2019s proprietary High-Precision Tunable Laser Spectroscopy (HPTLS\u2122) technology. TALOS\u2122 simplifies protein quantitation across biopharmaceutical workflows by replacing traditional variable pathlength UV workflows with fixed-path near-infrared (NIR) measurement of the peptide backbone. Protein quantitation is possible from 0.1 to 250 mg\/mL, in seconds from a 15 \u00b5L sample, without dilution, moving optical systems, molecule-specific calibration, or manual pathlength adjustment.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260603645287\/en\/2821750\/4\/logo_option_d.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260603645287\/en\/2821750\/22\/logo_option_d.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260603645287\/en\/2821750\/4\/logo_option_d.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260603645287\/en\/2821750\/21\/logo_option_d.jpg\" \/><\/a><p>\nTALOS\u2122 delivers rapid, consistent protein quantitation with the operational simplicity needed for modern bioprocessing workflows, from early process development through GMP manufacturing. With an unprecedented dynamic range, TALOS\u2122 can be used across the full bioprocess workflow as protein concentrations increase from harvest through downstream processing and final release testing. Designed for flexible at-line, in-line, and in situ deployment, TALOS\u2122 is transferable across different unit operations, scales, and manufacturing sites, creating greater consistency and confidence in protein quantitation.<\/p><p>\n\u201cProtein quantitation is performed throughout biopharmaceutical development and manufacturing, but traditional UV-based workflows introduce operational complexity and have limited deployment options, making it difficult to leverage across unit operations and scales,\u201d said Bryan Hassell, Ph.D., CEO of Nirrin Technologies. \u201cAs biologics manufacturing becomes more distributed, automated, and data-driven, the need for consistent, transferable protein quantitation across workflows and facilities becomes increasingly important. TALOS\u2122 is designed for modern biologics manufacturing. The system provides a more reliable and transferable approach to protein quantitation that simplifies operation, reduces workflow burden, and delivers consistent measurements across teams, manufacturing sites, and deployment environments.\"<\/p><p>\n<b>How the TALOS System is Designed for Manufacturing Workflows<\/b><\/p><p>\n<i>High Concentration Confidence<\/i><\/p><ul class=\"bwlistdisc\">\n<li>\nSupports protein quantitation from harvest through high-concentration formulation without dilution<\/li>\n<\/ul><p>\n<i>Transferability<\/i><\/p><ul class=\"bwlistdisc\">\n<li>\nConsistent quantitation architecture facilitates method transferability from process development through GMP manufacturing<\/li>\n<li>\nDesign enables at-line, in-line, and in situ measurements<\/li>\n<\/ul><p>\n<i>Operational Simplicity<\/i><\/p><ul class=\"bwlistdisc\">\n<li>\nFixed-path measurement architecture enables reliable, repeatable operation across users and sites<\/li>\n<li>\nTargeted NIR measurement of the peptide backbone reduces dependence on molecule-specific calibration workflows<\/li>\n<li>\nBuilt-in spectral residual and measurement quality metrics supports operational confidence and method monitoring<\/li>\n<\/ul><p>\n<i>GMP\/Integrated Architecture<\/i><\/p><ul class=\"bwlistdisc\">\n<li>\nIntegrated hardware, software, and analytics simplify deployment and validation<\/li>\n<li>\nAudit-ready GMP-aligned, 21 CFR Part 11\u2013capable workflows<\/li>\n<\/ul><p>\nUnlike variable pathlength UV systems that rely on moving optical components and slope-based calculations, TALOS\u2122 directly measures molecular vibrations associated with the peptide backbone in the NIR combination-band region through a fixed 1 mm optical pathlength. This fixed-path architecture eliminates mechanical pathlength adjustment while supporting robust, repeatable measurement performance across workflows and deployment configurations.<\/p><p>\nAll TALOS\u2122 configurations share a common quantitation architecture designed to support consistent measurement performance and method transferability across at-line, in-line, and in situ deployment modes. The at-line configuration of the TALOS\u2122 system is currently available. In-line flow cell and in situ probe configurations are in development for continuous real-time protein monitoring during processing without sampling.<\/p><p>\nTALOS\u2122 is available for order now in the United States, with availability expanding across North America, Europe and Japan. To request a demonstration or technical consultation, visit nirrin.tech\/talos or contact <a  href=\"mailto:info@nirrin.tech\" rel=\"nofollow\" shape=\"rect\">info@nirrin.tech<\/a>.<\/p><p>\n<b>About Nirrin Technologies<\/b><\/p><p>\nNirrin Technologies is transforming bioprocess analytics with proprietary High-Precision Tunable Laser Spectroscopy (HPTLS\u2122) technology. Nirrin\u2019s analytical instruments, including the Atlas\u2122 system for real-time process monitoring and the TALOS\u2122 protein quantitation system, provide advanced analytical solutions for complex biologics and advanced therapies, helping biopharmaceutical organizations reduce workflow complexity, improve process understanding, and accelerate development and manufacturing. For more information, visit nirrin.tech and follow Nirrin on <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fnirrin&amp;esheet=54546048&amp;newsitemid=20260603645287&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=8486ae3e82f7b2f4041d1cd58cdfb8e5\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>Media Contact:<\/b><br\/>Christine Quern\n<br\/>617-650-8497\n<br\/><a  href=\"mailto:cq@christinequern.com\" rel=\"nofollow\" shape=\"rect\">cq@christinequern.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Delivers rapid protein quantitation across bioprocess workflows from harvest to final formulation<\/p>\n<p>Reduces operator-dependent variables, simplifying protein quantitation for consistent and reliable operation across users and sites<\/p>\n<p>Supports protein q&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-15319","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15319"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15319\/revisions"}],"predecessor-version":[{"id":15320,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15319\/revisions\/15320"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}